Mar 4, 2024

Exeliom is awarded a $500k grant from the Crohn's and Colitis Foundation! 

📢 Exeliom is thrilled to announce that we have been awarded a $500k grant from the Crohn's and Colitis Foundation!


With this funding, we're committed to advancing our EXL01 program, dedicated to maintaining remission in Crohn’s Disease without compromising on patient well-being.


The foundation is on a mission; to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases.


Huge thanks to them for their unwavering support! 🙌


🤔 Curious to learn more about our innovative EXL01 program?


Click below to discover Exeliom’s innovative technology and our mission!

Back to news
#HealthcareInnovation #ClinicalTrial #CDI #Partnership #ExeliomBiosciences #HospicesCivilsdeLyon #MedicalResearch #HealthcareInnovation #ExeliomBiosciences #Biotech #Start-up #Microbiome #Cdiff
Nov 6, 2023
Exeliom Biosciences and Hospices Civils de Lyon announce clinical collaboration in recurrent Clostridioides difficile infection


Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.